Increased antimicrobial resistance during the COVID-19 pandemic

In addition to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the current status of the COVID-19 (coronavirus disease 2019) pandemic. There has been a rapid increase in multidrug-resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Chih-Cheng, Chen, Shey-Ying, Ko, Wen-Chien, Hsueh, Po-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972869/
https://www.ncbi.nlm.nih.gov/pubmed/33746045
http://dx.doi.org/10.1016/j.ijantimicag.2021.106324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972869/
https://www.ncbi.nlm.nih.gov/pubmed/33746045
http://dx.doi.org/10.1016/j.ijantimicag.2021.106324

Ejemplares similares